Patent · US Active

Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder

US11591622B2 · kind B2 · utility

0Cited by
40References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2019
Grant dateFeb 28, 2023
Priority date—
Expiry dateOct 6, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14141
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for targeted, nuclease-mediated insertion of transgene sequences into the genome of a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.